3 New Strong Buy Ratings from Top-Rated Analysts: 02/10/2026

By Jessie Moore, Stock Researcher and Writer
February 10, 2026 5:35 AM UTC
3 New Strong Buy Ratings from Top-Rated Analysts: 02/10/2026

Here are three Strong Buy picks for 2/10/2026:

  • Eli Lilly & Co (LLY) is coasting on the obesity drug trend 
  • FedEx (FDX) enjoys e-commerce tailwinds + more
  • Woodward (WWD) enjoys fresh highs during the aerospace boom

P.S. Speaking of hot, have you seen our video featuring a historical chart that seems eerily prescient for 2026? Check it out here.


A note from our sponsors...

The Hottest Investment Trend of 2026 (Not AI) Will you potentially make money or lose money in the U.S. stock market in 2026? According to the 50-year Wall Street legend who invented one of Wall Street's most popular buying and selling indicators - the answer has nothing to do with AI, quantum computing, or cryptos. Instead, it all comes down to the #1 stock he recommends you BUY now...And the #1 stock he recommends you SELL now.

1. Eli Lilly & Co (NYSE: LLY)

This pharmaceutical giant is capitalizing on explosive growth in its diabetes and obesity segments, with a robust pipeline poised to deliver significant near-term catalysts including upcoming clinical trial results for new diabetes medications.

Zen Rating: B (Buy) see full analysis

Recent Price: $1,058.18 — get current quote

Max 1-year forecast: $1,500.00

Why we're watching:

  • Analyst support: Right now, LLY enjoys 11 Strong Buy ratings, 3 Buy ratings, and 3 Hold ratings out of 17 total analysts we track covering the stock. See the ratings
  • For example, JP Morgan's Chris Schott (top 12%) set a bullish $1,300 price target, emphasizing that Eli Lilly is set to benefit from strong product sales in their diabetes and obesity segments with a robust pipeline expected to convert into marketable products soon.
  • Wells Fargo analyst Mohit Bansal (top 14%) raised his price target to $1,280, highlighting that LLY is well positioned to sustain revenue growth due to unique products and growing market share, with a major product launch imminent that will substantially impact earnings.
  • Industry ranking context: LLY is currently the 5th highest-rated stock in the General Drug Manufacturer industry, which has an Industry Rating of A.
  • Zen Rating highlights: Buy (B) stocks average +19.88%/yr — with strong demand and a strong pipeline, this seems like a realistic range for LLY. 
  • Component Grades: LLY demonstrates exceptional performance across the 7 Component Grades that shape the overall rating, with above-average Bs for Value, Growth, Momentum, Financials, and from our proprietary AI Factor. See all 7 Zen Component Grades here

2. Woodward (NASDAQ: WWD)

The aerospace revolution is real, and it’s benefiting this company — which, if you’re not familiar, manufactures, and services control solutions for the aerospace and industrial markets worldwide. The company recently hit fresh highs following better-than-expected earnings results, with analysts increasing forecasts based on strong momentum in both core business segments.

Zen Rating: A (Strong Buy) see full analysis

Recent Price: $392.00 — get current quote

Max 1-year forecast: $417.00

Why we're watching:

  • Analyst support: WWD has strong analyst conviction with 6 Strong Buy ratings, 1 Buy rating, and 1 Hold rating among 8 analysts covering the stock. See the ratings
  • Truist Securities' Michael Ciarmoli (a top 1% rated analyst) recently maintained his Strong Buy rating with a $404 price target following the company's earnings beat that sent shares to new highs.
  • UBS researcher Gavin Parsons (top 10%) set the street-high $417 price target, maintaining his Strong Buy rating as Woodward continues to demonstrate strong execution in aerospace and industrial control systems.
  • Industry ranking context: WWD is currently the 3rd highest-rated stock in the Defense industry, which has an Industry Rating of C.
  • Zen Rating highlights: With a Zen Rating of A (Strong Buy), WWD is in the top 5% of stocks we track overall — a grade that has historically resulted in outperformance.
  • Component Grades: Woodward excels with Growth at B and Artificial Intelligence at A, balanced by Value at C and Momentum at B, reflecting strong technological positioning in aerospace controls. See all 7 Zen Component Grades here

3. FedEx (NYSE: FDX)

The logistics leader is positioned to capitalize on e-commerce growth and international expansion, recently announcing a consortium to acquire parcel-delivery provider InPost for $9.2 billion.

Zen Rating: A (Strong Buy)see full analysis

Recent Price: $368.89 — get current quote

Max 1-year forecast: $412.00

Why we're watching:

  • Analyst support: FedEx commands significant Wall Street attention with 10 Strong Buy ratings, 6 Hold ratings, and 1 Strong Sell rating among the 17 total analysts we track issuing ratings. See the ratings
  • Citigroup's Ariel Rosa (a top 3% rated analyst) recently maintained his Strong Buy rating with a $401 price target following strong quarterly results, stating that FedEx has presented consistent growth metrics and is set to gain from e-commerce and international expansions.
  • UBS analyst Thomas Wadewitz (top 5%) set a $412 price target, noting that expectations for strong adoption of FedEx's services among SMEs are driving revenue growth, with FDX's pricing power continuing to strengthen supported by enhanced service offerings.
  • Wells Fargo's Christian Wetherbee (top 4%) recently upgraded the stock to Strong Buy with a $380 price target, citing improving operational metrics and rising fuel surcharges as signs of recovery, with the firm focused on international expansion.
  • Industry ranking context: FDX is currently the 1st highest-rated stock in the Logistics industry, which has an Industry Rating of B.
  • Zen Rating highlights: Strong Buy (A) stocks average +32.52%/yr — with exceptional fundamentals, FDX is in this elite tier that only includes the top 5% of stocks we track.
  • Component Grades: Fedex enjoys above-average Component Grades in several key areas, including Bs for Growth, Momentum, Safety, and our proprietary AI Factor. See all 7 Zen Component Grades here

What to Do Next?

Want to get in touch? Email us at news@wallstreetzen.com.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.